Bangladesh vs Low & middle income: Immunization, HepB3
Bangladesh
97.0%
in 2024
Low & middle income
83.6%
in 2024
Bangladesh rank
26th
Low & middle income rank
29th
Immunization, HepB3 over time
- Bangladesh
- Low & middle income
How they compare
Bangladesh currently reports 97.0% against 83.6% in Low & middle income, a difference of 13.4%.
That makes Bangladesh's figure about 1.2 times Low & middle income's.
The two have swapped places 1 time across 22 shared years of data; in 2003 it was Low & middle income ahead.
Bangladesh ranks 26th and Low & middle income ranks 29th of 188 countries.
Bangladesh has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bangladesh | Low & middle income | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 62.1% | 56.8% | 5.4% | Bangladesh |
| 2010s | 96.7% | 80.8% | 15.9% | Bangladesh |
| 2020s | 97.2% | 82.8% | 14.4% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Bangladesh or Low & middle income?
- Bangladesh, at 97.0% against 83.6% in Low & middle income as of 2024.
- What is the difference in immunization, hepb3 between Bangladesh and Low & middle income?
- 13.4%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Low & middle income?
- 22 years are reported by both, from 2003 to 2024.
- How do Bangladesh and Low & middle income rank globally for immunization, hepb3?
- Bangladesh ranks 26th and Low & middle income ranks 29th of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.